Narus Financial Partners’s Amgen AMGN Stock Holding History

Narus Financial Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Sell	641 -25	-4%	-$8.56K	0.06%	163
2026 Q1	$234K	Hold	666	–	–	0.06%	147
2025 Q4	$218K	Buy	+666	New	+$211K	0.06%	154
2025 Q2	–	Sell	-716	Closed	-$223K	–	158
2025 Q1	$223K	Buy	+716	New	+$211K	0.08%	138
2024 Q4	–	Sell	-716	Closed	-$231K	–	147
2024 Q3	$231K	Hold	716	–	–	0.08%	138
2024 Q2	$224K	Hold	716	–	–	0.09%	130
2024 Q1	$204K	Hold	716	–	–	0.09%	138
2023 Q4	$206K	Sell	716 -60	-8%	-$16.3K	0.1%	132
2023 Q3	$209K	Buy	+776	New	+$194K	0.11%	122
2023 Q1	–	Sell	-793	Closed	-$208K	–	112
2022 Q4	$208K	Buy	+793	New	+$213K	0.12%	112
2021 Q1	$214K	Buy	+860	New	+$205K	0.13%	102
2019 Q4	$207K	Buy	+860	New	+$190K	0.15%	77

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Narus Financial Partners's AMGN Position: Q2 2026 in Review

Narus Financial Partners reduced its Amgen (AMGN) stake by 3.8% in Q2 2026, selling an estimated $8.56K and leaving 641 shares worth $232K. The position accounts for 0.06% of the portfolio, ranked #163.

Narus Financial Partners first reported a position in AMGN in Q4 2019 and has held it in 12 quarters since. The position peaked at $234K in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Narus Financial Partners held 641 shares of Amgen worth $232K as of Q2 2026.
Narus Financial Partners sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
Amgen made up 0.06% of Narus Financial Partners's portfolio in Q2 2026, its #163 holding.
Narus Financial Partners first reported a position in Amgen in Q4 2019 and has held it in 12 quarters since.
Narus Financial Partners's Amgen position peaked at $234K in Q1 2026.
3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Narus Financial Partners's 13F filing for Q2 2026, filed 31 Jul 2026.